Blockade of FAS activity in the neuroblastoma cells eliminated the increase in tumor cell lysis observed in cells pretreated with the KDM1A inhibitor but did not impact CAR T cell-directed killing of untreated neuroblastoma cells (Figure 3C). Here, KDM1A is linked to neoplasm.